CDXC ChromaDex: Company Value to Revenue

Public company logo of ChromaDex Corporation (CDXC)

ChromaDex Corporation (CDXC) is scaling its business through B2B licensing of its patented Niagen component, thereby eliminating logistics costs. The firm's valuation based on the EV/Sales multiple reflects price action excluding debt, with the current level sitting around . The company is implementing ESG standards by reducing plastic use and expanding its global footprint through long-term contracts with brands without pursuing mergers.

CDXC ChromaDex Corp. EV/Sales Multiple (07/04/2022 - 11/20/2026)

Financial and market metric breakdowns for ChromaDex Corp. (CDXC)

- price and consensus price forecast:
- company stock capitalization data:
Fundamental valuation:ChromaDex Corp. CDXC
Core merchandise of ChromaDex

This indicator determines the business value excluding debt load by comparing market capitalization with sales volume to identify the actual price of the commercial model. An analysis of the EV/Sales ratio for ChromaDex Corporation (CDXC) confirms that the optimization of raw material logistics and the diversification of extractors are enhancing operational efficiency, rendering the current capital valuation resilient to market volatility.